Skip to main content
All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Informal coalition of health and consumer organizations and sunscreen industry companies

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 5
  • HR 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • S 2256
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • HR 3686
    SAFE Sunscreen Standards Act
  • S 355
    FDA Modernization Act 3.0
  • HR 2821
    FDA Modernization Act 3.0
 Lobbying activity 1
Medical/Disease Research/Clinical Labs

Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem